Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen
- PMID: 25459098
- DOI: 10.1016/j.contraception.2014.10.006
Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen
Abstract
Objectives: To compare bleeding patterns for 12 months continuous use of a contraceptive ring [contraceptive vaginal ring (CVR)] and pill [combined oral contraceptive (COC)] on a menstrually signaled regimen and the effectiveness of 4 days "treatment withdrawal" to stop bleeding.
Study design: Women, 66 to each group, were randomized to continuous use of a CVR (15 mcg ethinyl estradiol/150 mcg etonogestrel) or a low-dose pill (20 mcg ethinyl estradiol/100 mcg levonorgestrel) for 360 days on a menstrually signaled regimen. Bleeding/spotting days, daily use of ring or pill, was recorded. Endpoint was the total number of bleeding/spotting days for each method over four 90-day reference periods (RP) plus the analysis of bleeding patterns using modified World Health Organization criteria.
Results: There was a reduction in the mean (±S.D.) number of bleeding/spotting days from RP1 (CVR 14.2±10; pill 16.6±10.9) to RP4 (CVR 8.8±9.6; pill 8.8±9.1). Fifteen percent of CVR and 4% COC users experienced amenorrhea or infrequent bleeding throughout the study. Amenorrhea increased over time (RP1 vs. RP4: CVR 10% vs. 21% and COC 2% vs. 30%). Compliance with the menstrually signaled regimen was poor. Ceasing hormones for 4 days stopped a bleeding episode within 5 days in the majority of episodes and many stopped spontaneously.
Conclusion: Bleeding patterns with continuous use of the CVR and COC are similar and improve over 1 year of use. The unpredictability, but short duration, of bleeding episodes should be stressed during counseling.
Implication: This information for clinicians and women about breakthrough bleeding patterns with use of a CVR or combined pill over 12 months using a menstrually signaled regimen will give women an indication of what to expect with continuous use.
Keywords: Compliance; Convenience; Duration; Frequent bleeding/spotting.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Combined hormonal contraceptives for heavy menstrual bleeding.Cochrane Database Syst Rev. 2019 Feb 11;2(2):CD000154. doi: 10.1002/14651858.CD000154.pub3. Cochrane Database Syst Rev. 2019. PMID: 30742315 Free PMC article.
-
Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.Contraception. 2015 Feb;91(2):113-20. doi: 10.1016/j.contraception.2014.10.004. Epub 2014 Oct 13. Contraception. 2015. PMID: 25453585 Clinical Trial.
-
Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:147-51. doi: 10.1016/j.ejogrb.2016.05.009. Epub 2016 May 20. Eur J Obstet Gynecol Reprod Biol. 2016. PMID: 27285306 Clinical Trial.
-
Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.Br J Obstet Gynaecol. 1993 Sep;100(9):832-8. doi: 10.1111/j.1471-0528.1993.tb14309.x. Br J Obstet Gynaecol. 1993. PMID: 8218004 Clinical Trial.
-
Continuous oral contraception. Strategies for managing breakthrough bleeding.Adv Nurse Pract. 2008 Aug;16(8):36-8. Adv Nurse Pract. 2008. PMID: 19181174 Review. No abstract available.
Cited by
-
Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the hematologist's view.Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):152-157. doi: 10.1182/hematology.2019000022. Hematology Am Soc Hematol Educ Program. 2019. PMID: 31808846 Free PMC article.
-
Combined hormonal contraceptives for heavy menstrual bleeding.Cochrane Database Syst Rev. 2019 Feb 11;2(2):CD000154. doi: 10.1002/14651858.CD000154.pub3. Cochrane Database Syst Rev. 2019. PMID: 30742315 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources